logo
  

St. Jude Medical (STJ) Is Up Sharply On Reports Of Takeover Interest

The Financial Times reported Thursday morning that Abbott Laboratories (ABT) is preparing a $25 billion cash and stock bid to acquire St. Jude Medical Inc. (STJ). Abbott Laboratories later denied the report.

St. Jude Medical gapped open sharply higher Thursday and is now up 2.81 at $72.15 on the highest volume in 4 months. The stock has jumped to a 1-week high.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT